Clinical trial

Milrinone in Congenital Diaphragmatic Hernia

NCT02951130

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-10-24

PhasePHASE2

Study timeline

Study start (actual)2017-10-24Date precision: day

Registry last updated2025-11-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Congenital Diaphragmatic Herniaunresolved

Persistent Pulmonary Hypertension of the Newbornunresolved

Hypoxemic Respiratory Failureunresolved

Pulmonary Hypoplasiaunresolved

Interventions

MilrinoneDRUG · verified · RxNorm: milrinone

Placebo (5% Dextrose)DRUG

Sponsors & collaborators

NICHD Neonatal Research Networklead sponsor

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)collaborator

Mapped research locations

DurhamNorth Carolina, United States2 New YorkNew York, United States1 HoustonTexas, United States1 PhiladelphiaPennsylvania, United States1 DallasTexas, United States1 AtlantaGeorgia, United States1 ClevelandOhio, United States1 BirminghamAlabama, United States1 CincinnatiOhio, United States1 ColumbusOhio, United States1 RochesterNew York, United States1 Salt Lake CityUtah, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02951130 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.